INTRODUCTION
Adherent human neutrophils interacting with purified chemotactic factors demonstrated a two-to six-fold increase in the activity of their hexose monophosphate shunt (HMPS)' (1 Received for publication 16 July 1973 and in revised form 5 October 1973. lAbbreviations used in this paper: AU, absorbancy units; ECF-A, eosinophil chemotactic factor of anaphylaxis; HMPS, hexose monophosphate shunt; hpf, high power chemotactic response of mobile leukocytes, such as treatment with diisopropyl fluorophosphate or with the neutrophil-immobilizing factor (NIF), did not prevent stimulation of the HMPS of adherent neutrophils. Although stimulation of the HMPS alone was not sufficient for chemotaxis, preincubation with 6-aminonicotinamide, which blocked the enhanced HMPS activity associated with the introduction of a chemotactic stimulus, partially suppressed the chemotactic response to diverse stimuli (2) . To assess further the relationship of HMPS stimulation to a chemotactic response, ascorbic acid, which is known to increase leukocyte HMPS activity (1, 3) , was examined for its effect on the random migration and chemotaxis of human leukocytes. METHODS
Polystyrene disposable chemotactic chambers (Adaps, Inc., Dedham, Mass.) and acrylic radiochemotactic chambers (Neuro Probe, Inc., Bethesda, Md.) were assembled with 3-gm and 8-,um pore size micropore filters (Millipore Corp., Bedford, Mass.) as previously described (4, 5 7.4 in an ice bath by dropwise addition of 0.4 N NaOH. NIF, derived from 1 X 107 lhuman leukocytes which had either been incubated at 37'C in 1 ml of buffer alone (control for NIF) or engaged in plhagocytosis of starch particles (PhNIF), was partially purified by heating and by gel filtration on Sephadex G-25 (4).
Gamma radiation from 5"Cr-containing micropore filters used in radiochemotactic chambers was measured with a dual-channel gamma well counter, and beta radiation from Collection and purification of human leuikocytes. Mixed peripheral leukocytes from normal human subjects were collected and separated from erythrocytes by dextran sedimentation, and the contaminating erythrocytes were lysed with 0.84%o NH4Cl as previously described (1) . Neutrophils and mononuclear leukocytes were further purified by centrifugation of mixed leukocytes on Ficoll-Hypaque cushions (6) . Eosinophils from patients with hypereosinophilic syndromes were purified from mixed leukocytes in dextrantreated plasma by centrifugation on metrizoate cushions (7) . All leukocytes were washed twice with Hanks's solution before their function was assessed.
Aleasuremitent of chemotaxis anid random miigration.
Chemotaxis of human leukocytes was assayed by a previously detailed modification (4) of the Boyden micropore filter assay, employing 3-,Lm micropore filters for neutrophils, eosinophils, and mixed leukocytes, and 8-,um micropore filters for mononuclear leukocytes (8) , and also by a radiochemotactic method which utilizes modified chambers that hold a layer of two micropore filters between 51Cr-labeled leukocytes and the chemotactic stimulus (5) . The medium for all cells was Hanks's balanced salt solution-0.5 g per 100 ml in ovalbumin (pH 7.4). The chemotactic factors were eosinophil chemotactic factor of anaphylaxis (ECF-A) purified from anaphylactic diffusates of human lung by Sephadex G-25 chromatogra,phy (9), human C5a generated by tryptic digestion of highly purified C5 (10) , and human kallikrein generated from purified prekallikrein by activation with Hageman factor fragments (11) . For the modified Boyden technique, initial cell suspensions contained 1.5-2.0 X 106 cells and the incubation time was 21> h. The leukocyte counts were expressed as the mean of 10 high power fields (hpf), 5 from each of duplicate chambers, corrected for background counts in filters from chambers without a chemotactic stimulus. For the radiochemotactic procedure, the initial cell suspensions contained 5-6 X 10' cells and the incubation time was (Fig. 1) and directed leukotaxis in response to the chemotactic stimuli, C5a (Fig. 1) 1 Enhancement by ascorbate of random migration and chemotactic response by mixed human leukocytes. The modified Boyden assay was used to assess random migration and the chemotactic response to C5a of mixed human leukocytes. C5a, produced by tryptic digestion of C5, was present at a final concentration equivalent to that derived from 10 ,tg of C5 per ml. The ascorbate concentration was 2.5 X 10" M. Cells were preincubated with ascorbate and introduced into the chambers without washing (leukocyte side), ascorbate was placed into the stimulus compartment alone (stimulus side), or these two maneuvers were combined (both sides). nate a concentration gradient allowed for a maximum enhancement of random migration and chemotaxis. The random migration of purified human neutrophils, eosinophils, and mononuclear leukocytes, and the chemotactic response of these leukocytes to the selective stimuli, kallikrein, ECF-A, and C5a, respectively, were each enhanced by exposure of the leukocytes to ascorbate (Fig.  2) . The capacity of ascorbate to enhance directed and random migration of neutrophils did not extend to an effect on erythrophagocytosis (Fig. 3) .
Relationship of enhancement of leukocyte mobility by ascorbate to stimulation of HMPS activity. The activity of the HMPS of neutrophils was increased by the addition of ascorbate, with a dose-response relationship comparable to that found for the stimulation by ascorbate of random mobility (Fig. 3) . The stimulation of both random migration and the activity of the HMPS of human leukocytes by two concentrations of ascorbate falling on the plateau of the dose-response curve was partially reversible with washing of the cells (Table I) . The augmentation of the activity of the HMPS by ascorbate alone or in combination with C5a was greater than 90% reversible by washing the leukocytes. The enhanced random migration by ascorbate was also largely reversible upon washing of the leukocytes, while the enhancement of directed migration was only partially reversed by washing. The action of ascorbate was not unique, since glutathione which also stimulated HMPS activity enhanced random migration and chemotaxis of human leukocytes with similar dose-response patterns (Fig. 4) . Methylene blue, the most potent agent in terms of HMPS stimulation, had no effect on migration, and therefore, HMPS stimulation was not alone sufficient to enhance migration.
Inhibition of the ascorbate effect on leukocyte mobility. Prior incubation of neutrophils with either 6-aminonicotinamide, which blocks HMPS activity by competing with NADP+ (13), or low concentrations of the alkylating agent iodoacetate resulted in concomitant inhibition of enhanced HMPS activity and random migration (Table II) . These doses did not affect base-line glycolytic activity, which was also not influenced by ascorbate. In contrast, NIF, which specifically inhibits both random and directed migration of these human neutrophils, had virtually no effect on the augmentation of random migration and HMPS activity by ascorbate.
DISCUSSION
Exposure of human peripheral leukocytes to ascorbic acid at neutral pH increased both the random migration of the leukocytes and their chemotactic responsiveness to diverse stimuli by 100-300%, without influencing their phagocytic capacity (Figs. 1, 3 I Leukocyte migration refers to enhanced migration with ascorbate alone or chemotaxis with the C5a stimulus, both measured by the [5'Cr]leukocyte method. § CSa was produced by digestion of C5 with trypsin followed by dilution to a final concentration equivalent to that derived from 3 ,g C5 per ml. particular leukocyte type or chemotactic factor (Fig. 2) , since stimulation was observed for isolated neutrophils, eosinophils, and mononuclear leukocytes in terms of their random mobility and their response to a chemotactic factor specifically appropriate to each, namely kallikrein, (Fig. 3) .
As ascorbate had been observed to increase the activity of the HMPS of human leukocytes (1, 3) , the relationship between this stimulation and the enhanced mobility produced by ascorbate was examined in terms of dose-response relationship, reversibility, and the influence of metabolic inhibitors. The presumed mechanism of the ascorbate effect was the conversion of ascorbate to dehydroascorbate, which occurs rapidly and spontaneously at neutral pH conditions, followed by, presumably via the glutathione shuttle, the oxidation of NADPH by dehydroascorbate to NADP*, the coenzyme in the rate-limiting initial step of the HMPS (3). The stimulation of HMPS activity and migration by glutathione (Fig. 4) supports its role as an intermediate between dehydroascorbate and NADPH. Ascorbate is not itself a chemotactic factor, and its action in augmenting random and directed mobility is dependent upon its prior interaction with the leukocytes (Fig. 1) . There is a dose-response relationship between the effect of ascorbate on HMPS activity and neutrophil mobility (Fig. 3) , and both are reversed by washing (Table I ). In addition, treatment of leukocytes with 6-aminonicotinamide or iodoacetate so as to inhibit stimulation of the HMPS by ascorbate resulted in complete blockage of enhancement by ascorbate of random migration (Table II) and chemotaxis. This inhibition of mobility by 6-aminonicotinamide was more profound than that previously demonstrated for suppression of chemotaxis in the absence of ascorbate (2) . Thus, although the failure of methylene blue to enhance migration demonstrates that HMPS stimulation is not alone sufficient, it appears that ascorbate enhancement of random migration and chemotaxis is dependent upon stimulation of HMPS.
Previous work (1, 4) showed that irreversible inhibition of human neutrophil directed and random mobility by NIF was not lethal to the cells and was functionally specific, since neither neutrophil phagocytosis nor adherence to surfaces was altered by NIF. The concomitant finding that NIF did not suppress stimulation of the HMPS during phagocytosis, nor after introduction of a chemotactic factor, (1) has now been extended to show that NIF does not prevent ascorbate enhancement of HMPS activity (Table II) . In addition, the failure of NIF to suppress ascorbate augmentation of mobility contrasts with previous studies (1, 4) in which this factor rapidly suppressed polymorphonuclear leukocyte mobility.
It was demonstrated more than two decades ago that deficiency of ascorbate resulted in impaired phagocytosis by leukocytes, a defect which could be reversed by the addition of exogenous ascorbate (14) . However, while concentrations of ascorbate 10-50 times the usual plasma level (15) did not enhance the phagocytic capacity of human leukocytes (Fig. 3) , these concentrations were effective in enhancing leukocyte mobility in vitro. Human leukocytes, as well as the choroid plexus, cerebral cortex, kidney, and eye, concentrate ascorbate to levels comparable to those which were associated with the augmentation of random and directed leukocyte mobility (16) (17) (18) (19) (20) . It may well be that the high ascorbate levels in some tissues contribute to their ability to mount an inflammatory reaction in response to infection or other noxious stimuli.
